{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T08:40:46Z","timestamp":1787820046434,"version":"build-2784847793"},"reference-count":54,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Autism"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:p>Genetic tests, such as Fragile X and Chromosomal Microarray, are recommended as a standard of care during the evaluation of autism spectrum disorder (ASD) and other neurodevelopmental disorders. However, previous research demonstrates low rates of genetic testing. This study aimed to identify the rates of genetic testing and patient demographic factors that may be associated by conducting a retrospective chart review of 7539 electronic health records of patients who were evaluated for ASD or other neurodevelopmental disorders within a university healthcare network. Researchers created a database that listed patient demographics (race, gender, insurance, zip code), records of ordered but not completed tests, genetic test results and reasons for declining genetic tests (if noted), and other known barriers to genetic testing. Statistical analyses were conducted to determine associations between genetic testing rates and sociodemographic factors. 30.57% of patients received at least one indicated genetic test, while 11.31% received recommended concordant genetic testing. Findings suggest that while gender did not impact whether a patient received at least one genetic test, race and insurance did. Our review demonstrates that genetic testing is not sufficiently offered by physicians, and there are multiple barriers preventing patients from receiving genetic testing, which must be further investigated.<\/jats:p>\n                  <jats:sec>\n                    <jats:title>Lay abstract<\/jats:title>\n                    <jats:p>Genetic testing is recommended by various professional organizations as part of clinical guidelines during the evaluation of autism spectrum disorder (ASD) and other neurodevelopmental disorders. However, previous studies demonstrate that rates of genetic testing are low. This study aimed to identify the rates of genetic testing within a large university healthcare network and factors that may be associated with higher or lower rates. Researchers reviewed over 7500 electronic health records of patients who were evaluated for ASD or other neurodevelopmental disorders. Some factors that were recorded include patient demographics (race, gender, insurance, zip code), ordered but not completed tests, genetic test results and reasons for declining genetic tests if noted, and other known barriers to genetic testing such as blood draws and specialties of providers seen by patients. Statistical analysis was conducted to determine associations between rates of genetic testing and different factors recorded in our database. Our results demonstrate that less than half of patients received at least one indicated genetic test, while a smaller percentage received recommended genetic tests. While sex assigned at birth and gender did not impact whether a patient received at least one indicated genetic test, race and insurance did. Our review reveals that genetic testing is not sufficiently offered by physicians, and we have identified multiple obstacles that prevent patients from receiving genetic testing which must be further investigated.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/13623613241289980","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T06:24:28Z","timestamp":1736231068000},"page":"698-710","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Determining rates of genetic testing in the evaluation of autism spectrum disorder and intellectual and developmental disorder"],"prefix":"10.1177","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7575-4732","authenticated-orcid":false,"given":"Kyla","family":"Arcebido","sequence":"first","affiliation":[{"name":"University of Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0892-4144","authenticated-orcid":false,"given":"Emily Val","family":"Tuliao","sequence":"additional","affiliation":[{"name":"University of Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3470-0555","authenticated-orcid":false,"given":"Andryella Maxie","family":"Ibarra","sequence":"additional","affiliation":[{"name":"University of Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7288-9485","authenticated-orcid":false,"given":"Kai","family":"Russell","sequence":"additional","affiliation":[{"name":"University of Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9888-4489","authenticated-orcid":false,"given":"Aracelly","family":"Valdes","sequence":"additional","affiliation":[{"name":"University of Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7635-5069","authenticated-orcid":false,"given":"Sohum","family":"Shinkre","sequence":"additional","affiliation":[{"name":"University of Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3167-3638","authenticated-orcid":false,"given":"Samantha","family":"Gefen","sequence":"additional","affiliation":[{"name":"University of Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Evans","sequence":"additional","affiliation":[{"name":"University of Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1980-045X","authenticated-orcid":false,"given":"Sabrina","family":"Barella","sequence":"additional","affiliation":[{"name":"University of Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1504-1748","authenticated-orcid":false,"given":"Joelle","family":"Wadei","sequence":"additional","affiliation":[{"name":"University of Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Quinon","sequence":"additional","affiliation":[{"name":"University of Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6268-2965","authenticated-orcid":false,"given":"Takahiro","family":"Soda","sequence":"additional","affiliation":[{"name":"University of Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"crossref","unstructured":"Abul-Husn N. S. Owusu Obeng A. Sanderson S. C. Gottesman O. Scott S. A. (2014). Implementation and utilization of genetic testing in personalized medicine. Pharmacogenomics and Personalized Medicine 7 227\u2013240. https:\/\/doi.org\/10.2147\/PGPM.S48887","DOI":"10.2147\/PGPM.S48887"},{"key":"e_1_3_3_3_1","doi-asserted-by":"crossref","unstructured":"Al-Beltagi M. (2021). Autism medical comorbidities. World Journal of Clinical Pediatrics 10(3) 15\u201328. https:\/\/doi.org\/10.5409\/wjcp.v10.i3.15","DOI":"10.5409\/wjcp.v10.i3.15"},{"key":"e_1_3_3_4_1","author":"Andrews A.","year":"2015","unstructured":"Andrews A., St.Aubyn B. (2015). \u201cIf it\u2019s not written down; It didn\u2019t happen. . .\u201d. https:\/\/www.jcn.co.uk\/journals\/issue\/10-2015\/article\/if-its-not-written-down-it-didnt-happen","journal-title":"\u201cIf it\u2019s not written down; It didn\u2019t happen. . .\u201d"},{"key":"e_1_3_3_5_1","unstructured":"Autism Spectrum Disorder Family Health History and Genetics\u2014CDC. (2023 September 7). Retrieved December 31 2024 from https:\/\/www.cdc.gov\/autism\/about\/index.html"},{"key":"e_1_3_3_6_1","doi-asserted-by":"crossref","unstructured":"Aylward B. S. Gal-Szabo D. E. Taraman S. (2021). Racial ethnic and sociodemographic disparities in diagnosis of children with autism spectrum disorder. Journal of Developmental and Behavioral Pediatrics 42(8) 682\u2013689. https:\/\/doi.org\/10.1097\/DBP.0000000000000996","DOI":"10.1097\/DBP.0000000000000996"},{"key":"e_1_3_3_7_1","doi-asserted-by":"crossref","unstructured":"Bai D. Yip B. H. K. Windham G. C. Sourander A. Francis R. Yoffe R. Glasson E. Mahjani B. Suominen A. Leonard H. Gissler M. Buxbaum J. D. Wong K. Schendel D. Kodesh A. Breshnahan M. Levine S. Z. Parner E. T. Hansen S. N. . . .Sandin S. (2019). Association of genetic and environmental factors with autism in a 5-country cohort. JAMA Psychiatry 76(10) 1035\u20131043. https:\/\/doi.org\/10.1001\/jamapsychiatry.2019.1411","DOI":"10.1001\/jamapsychiatry.2019.1411"},{"key":"e_1_3_3_8_1","doi-asserted-by":"crossref","unstructured":"Barton K. Tabor H. K. Starks H. Garrison N. A. Laurino M. Burke W. (2018 August 25). Pathways from autism spectrum disorder (ASD) diagnosis to genetic testing\u2014PMC. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5908763\/","DOI":"10.1038\/gim.2017.166"},{"key":"e_1_3_3_9_1","unstructured":"Bogart K. (n.d.). Behavioral challenges in Fragile X syndrome. National Fragile X Foundation. https:\/\/fragilex.org\/professional-resources\/treatment-recommendations\/behavioral-challenges-in-fragile-x-syndrome\/"},{"key":"e_1_3_3_10_1","doi-asserted-by":"crossref","unstructured":"Chen L.-S. Xu L. Huang T.-Y. Dhar S. U. (2013). Autism genetic testing: A qualitative study of awareness attitudes and experiences among parents of children with autism spectrum disorders. Genetics in Medicine 15(4) 274\u2013281. https:\/\/doi.org\/10.1038\/gim.2012.145","DOI":"10.1038\/gim.2012.145"},{"key":"e_1_3_3_11_1","doi-asserted-by":"crossref","unstructured":"Clayton E. W. Evans B. J. Hazel J. W. Rothstein M. A. (2019). The law of genetic privacy: Applications implications and limitations. Journal of Law and the Biosciences 6(1) 1\u201336. https:\/\/doi.org\/10.1093\/jlb\/lsz007","DOI":"10.1093\/jlb\/lsz007"},{"key":"e_1_3_3_12_1","doi-asserted-by":"crossref","unstructured":"\u00c7\u00f6p E. Yurtba\u015fi P. \u00d6ner \u00d6. M\u00fcnir K. M. (2015). Genetic testing in children with autism spectrum disorders. Anadolu Psikiyatri Dergisi 16(6) 426\u2013432. https:\/\/doi.org\/10.5455\/apd.1414607917","DOI":"10.5455\/apd.1414607917"},{"key":"e_1_3_3_13_1","doi-asserted-by":"crossref","unstructured":"Dusic E. J. Theoryn T. Wang C. Swisher E. M. Bowen D. J. & EDGE Study Team (2022). Barriers interventions and recommendations: Improving the genetic testing landscape. Frontiers in Digital Health 4 Article 961128. https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2022.961128","DOI":"10.3389\/fdgth.2022.961128"},{"key":"e_1_3_3_14_1","unstructured":"Fletcher-Dallas R. (2016 July 21). Benefits and risks of genetic testing. Genetic Alliance UK. https:\/\/geneticalliance.org.uk\/information\/service-and-testing\/benefits-and-risks-of-genetic-testing\/"},{"key":"e_1_3_3_15_1","unstructured":"The Florida Senate. (n.d.). https:\/\/www.flsenate.gov\/Session\/Bill\/2020\/1564\/?Tab=BillHistory"},{"key":"e_1_3_3_16_1","unstructured":"Fragile X Syndrome Testing & Diagnosis\u2014Fragile X 101. (n.d.). https:\/\/fragilex.org\/understanding-fragile-x\/fragile-x-101\/testing-diagnosis\/"},{"key":"e_1_3_3_17_1","doi-asserted-by":"crossref","unstructured":"Garrido-Torres N. Marqu\u00e9s Rodr\u00edguez R. Alemany-Navarro M. S\u00e1nchez-Garc\u00eda J. Garc\u00eda-Cerro S. Ayuso M. I. Gonz\u00e1lez-Meneses A. Martinez-Mir A. Ruiz-Veguilla M. Crespo-Facorro B. (2024). Exploring genetic testing requests genetic alterations and clinical associations in a cohort of children with autism spectrum disorder. European Child & Adolescent Psychiatry 33 3829\u20133840. https:\/\/doi.org\/10.1007\/s00787-024-02413-x","DOI":"10.1007\/s00787-024-02413-x"},{"key":"e_1_3_3_18_1","unstructured":"Genetic discrimination. (n.d.). https:\/\/www.genome.gov\/about-genomics\/policy-issues\/Genetic-Discrimination"},{"key":"e_1_3_3_19_1","doi-asserted-by":"crossref","unstructured":"Guo F. Hirth J. M. Fuchs E. L. Cofie L. E. Brown V. Kuo Y.-F. Fernandez M. E. Berenson A. B. (2022). Knowledge attitudes willingness to pay and patient preferences about genetic testing and subsequent risk management for cancer prevention. Journal of Cancer Education: The Official Journal of the American Association for Cancer Education 37(2) 362\u2013369. https:\/\/doi.org\/10.1007\/s13187-020-01823-0","DOI":"10.1007\/s13187-020-01823-0"},{"key":"e_1_3_3_20_1","doi-asserted-by":"crossref","unstructured":"Harris E. (2023). Trofinetide receives FDA approval as first drug for Rett syndrome. JAMA 329(14) 1142. https:\/\/doi.org\/10.1001\/jama.2023.4003","DOI":"10.1001\/jama.2023.4003"},{"key":"e_1_3_3_21_1","doi-asserted-by":"crossref","unstructured":"Harris H. K. Sideridis G. D. Barbaresi W. J. Harstad E. (2020). Pathogenic yield of genetic testing in autism spectrum disorder. Pediatrics 146(4) e20193211. https:\/\/doi.org\/10.1542\/peds.2019-3211","DOI":"10.1542\/peds.2019-3211"},{"key":"e_1_3_3_22_1","doi-asserted-by":"crossref","unstructured":"Hellquist A. Tammimies K. (2022). Access utilization and awareness for clinical genetic testing in autism spectrum disorder in Sweden: A survey study. Autism 26(7) 1795\u20131804. https:\/\/doi.org\/10.1177\/13623613211066130","DOI":"10.1177\/13623613211066130"},{"key":"e_1_3_3_23_1","doi-asserted-by":"crossref","unstructured":"Hudson K. L. (2007). Prohibiting genetic discrimination. The New England Journal of Medicine 356(20) 2021\u20132023. https:\/\/doi.org\/10.1056\/NEJMp078033","DOI":"10.1056\/NEJMp078033"},{"key":"e_1_3_3_24_1","doi-asserted-by":"crossref","unstructured":"Hyman S. L. Levy S. E. Myers S. M. Council on Children with Disabilities Section on Developmental and Behavioral Pediatrics Kuo D. Z. Apkon S. Davidson L. F. Ellerbeck K. A. Foster J. E. A. Noritz G. H. Leppert M. O. Saunders B. S. Stille C. Yin L. Weitzman C. C. Childers D. O. Levine J. M. Peralta-Carcelen A. M. Poon J. K. . . . Bridgemohan C. (2020). Identification evaluation and management of children with autism spectrum disorder. Pediatrics 145(1) e20193447. https:\/\/doi.org\/10.1542\/peds.2019-3447","DOI":"10.1542\/peds.2019-3447"},{"key":"e_1_3_3_25_1","doi-asserted-by":"crossref","unstructured":"Jadav N. Bal V. H. (2022). Associations between co-occurring conditions and age of autism diagnosis: Implications for mental health training and adult autism research. Autism Research 15(11) 2112\u20132125. https:\/\/doi.org\/10.1002\/aur.2808","DOI":"10.1002\/aur.2808"},{"key":"e_1_3_3_26_1","doi-asserted-by":"crossref","unstructured":"Johannessen J. N\u00e6rland T. Hope S. Torske T. H\u00f8yland A. L. Strohmaier J. Heiberg A. Rietschel M. Djurovic S. Andreassen O. A. (2017). Parents\u2019 attitudes toward clinical genetic testing for autism spectrum disorder\u2014Data from a Norwegian sample. International Journal of Molecular Sciences 18(5) 1078. https:\/\/doi.org\/10.3390\/ijms18051078","DOI":"10.3390\/ijms18051078"},{"key":"e_1_3_3_27_1","doi-asserted-by":"crossref","unstructured":"Joly Y. Dalpe G. (2022). Genetic discrimination still casts a large shadow in 2022. European Journal of Human Genetics 30(12) 1320\u20131322. https:\/\/doi.org\/10.1038\/s41431-022-01194-8","DOI":"10.1038\/s41431-022-01194-8"},{"key":"e_1_3_3_28_1","doi-asserted-by":"crossref","unstructured":"Lichtenstein P. Tideman M. Sullivan P. F. Serlachius E. Larsson H. Kuja-Halkola R. Butwicka A. (2022). Familial risk and heritability of intellectual disability: A population-based cohort study in Sweden. Journal of Child Psychology and Psychiatry 63(9) 1092\u20131102. https:\/\/doi.org\/10.1111\/jcpp.13560","DOI":"10.1111\/jcpp.13560"},{"key":"e_1_3_3_29_1","doi-asserted-by":"crossref","unstructured":"Manickam K. McClain M. R. Demmer L. A. Biswas S. Kearney H. M. Malinowski J. Massingham L. J. Miller D. Yu T. W. Hisama F. M. & ACMG Board of Directors. (2021). Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: An evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine: Official Journal of the American College of Medical Genetics 23(11) 2029\u20132037. https:\/\/doi.org\/10.1038\/s41436-021-01242-6","DOI":"10.1038\/s41436-021-01242-6"},{"key":"e_1_3_3_30_1","doi-asserted-by":"crossref","unstructured":"McCandless S. E. & The Committee on Genetics. (2011). Health supervision for children with Prader-Willi syndrome. Pediatrics 127(1) 195\u2013204. https:\/\/doi.org\/10.1542\/peds.2010-2820","DOI":"10.1542\/peds.2010-2820"},{"key":"e_1_3_3_31_1","doi-asserted-by":"crossref","unstructured":"Moreno-De-Luca D. Kavanaugh B. C. Best C. R. Sheinkopf S. J. Phornphutkul C. Morrow E. M. (2020). Clinical genetic testing in autism spectrum disorder in a large community-based population sample. JAMA Psychiatry 77(9) 979\u2013981. https:\/\/doi.org\/10.1001\/jamapsychiatry.2020.0950","DOI":"10.1001\/jamapsychiatry.2020.0950"},{"key":"e_1_3_3_32_1","doi-asserted-by":"crossref","unstructured":"Morris E. O\u2019Donovan M. Virani A. Austin J. (2022). An ethical analysis of divergent clinical approaches to the application of genetic testing for autism and schizophrenia. Human Genetics 141(5) 1069\u20131084. https:\/\/doi.org\/10.1007\/s00439-021-02349-1","DOI":"10.1007\/s00439-021-02349-1"},{"key":"e_1_3_3_33_1","doi-asserted-by":"crossref","unstructured":"Polymeropoulos C. M. Brooks J. Czeisler E. L. Fisher M. A. Gibson M. M. Kite K. Smieszek S. P. Xiao C. Elsea S. H. Birznieks G. Polymeropoulos M. H. (2021). Tasimelteon safely and effectively improves sleep in Smith\u2013Magenis syndrome: A double-blind randomized trial followed by an open-label extension. Genetics in Medicine 23(12) 2426\u20132432. https:\/\/doi.org\/10.1038\/s41436-021-01282-y","DOI":"10.1038\/s41436-021-01282-y"},{"key":"e_1_3_3_34_1","unstructured":"REDCap. (n.d.). https:\/\/redcap.ctsi.ufl.edu\/redcap\/"},{"key":"e_1_3_3_35_1","doi-asserted-by":"crossref","unstructured":"Sabatello M. Chen Y. Zhang Y. Appelbaum P. S. (2019). Disability inclusion in precision medicine research: A first national survey. Genetics in Medicine: Official Journal of the American College of Medical Genetics 21(10) 2319\u20132327. https:\/\/doi.org\/10.1038\/s41436-019-0486-1","DOI":"10.1038\/s41436-019-0486-1"},{"key":"e_1_3_3_36_1","doi-asserted-by":"crossref","unstructured":"Sandin S. Lichtenstein P. Kuja-Halkola R. Hultman C. Larsson H. Reichenberg A. (2017). The heritability of autism spectrum disorder. JAMA 318(12) 1182\u20131184. https:\/\/doi.org\/10.1001\/jama.2017.12141","DOI":"10.1001\/jama.2017.12141"},{"key":"e_1_3_3_37_1","doi-asserted-by":"crossref","unstructured":"Savatt J. M. Myers S. M. (2021). Genetic testing in neurodevelopmental disorders. Frontiers in Pediatrics 9 Article 526779. https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.526779","DOI":"10.3389\/fped.2021.526779"},{"key":"e_1_3_3_38_1","doi-asserted-by":"crossref","unstructured":"Schaefer G. B. Mendelsohn N. J. (2013). Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions. Genetics in Medicine 15(5) 399\u2013407. https:\/\/doi.org\/10.1038\/gim.2013.32","DOI":"10.1038\/gim.2013.32"},{"issue":"4","key":"e_1_3_3_39_1","first-page":"381","article-title":"Spiritual faith and genetic testing decisions among high-risk breast cancer probands","volume":"9","author":"Schwartz M. D.","year":"2000","unstructured":"Schwartz M. D., Hughes C., Roth J., Main D., Peshkin B. N., Isaacs C., Kavanagh C., Lerman C. (2000). Spiritual faith and genetic testing decisions among high-risk breast cancer probands. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 9(4), 381\u2013385.","journal-title":"Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology"},{"key":"e_1_3_3_40_1","doi-asserted-by":"crossref","unstructured":"Shim R. S. (2021). Dismantling structural racism in psychiatry: A path to mental health equity. American Journal of Psychiatry 178(7) 592\u2013598. https:\/\/doi.org\/10.1176\/appi.ajp.2021.21060558","DOI":"10.1176\/appi.ajp.2021.21060558"},{"key":"e_1_3_3_41_1","doi-asserted-by":"crossref","unstructured":"Srivastava S. Love-Nichols J. A. Dies K. A. Ledbetter D. H. Martin C. L. Chung W. K. Firth H. V. Frazier T. Hansen R. L. Prock L. Brunner H. Hoang N. Scherer S. W. Sahin M. Miller D. T. & NDD Exome Scoping Review WorkGroup. (2019). Meta-analysis and multidisciplinary consensus statement: Exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders. Genetics in Medicine: Official Journal of the American College of Medical Genetics 21(11) 2413\u20132421. https:\/\/doi.org\/10.1038\/s41436-019-0554-6","DOI":"10.1038\/s41436-019-0554-6"},{"key":"e_1_3_3_42_1","doi-asserted-by":"crossref","unstructured":"Sterling R. Henderson G. E. Corbie-Smith G. (2006). Public willingness to participate in and public opinions about genetic variation research: A review of the literature. American Journal of Public Health 96(11) 1971\u20131978. https:\/\/doi.org\/10.2105\/AJPH.2005.069286","DOI":"10.2105\/AJPH.2005.069286"},{"key":"e_1_3_3_43_1","unstructured":"Sun F. Oristaglio J. Levy S. E. Hakonarson H. Sullivan N. Fontanarosa J. Schoelles K. M. (2015). Genetic testing for developmental disabilities intellectual disability and autism spectrum disorder. Agency for Healthcare Research and Quality. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK304462\/"},{"key":"e_1_3_3_44_1","doi-asserted-by":"crossref","unstructured":"Tick B. Bolton P. Happ\u00e9 F. Rutter M. Rijsdijk F. (2016). Heritability of autism spectrum disorders: A meta-analysis of twin studies. Journal of Child Psychology and Psychiatry and Allied Disciplines 57(5) 585\u2013595. https:\/\/doi.org\/10.1111\/jcpp.12499","DOI":"10.1111\/jcpp.12499"},{"key":"e_1_3_3_45_1","unstructured":"Unique\u2014Understanding Rare Chromosome and Gene Disorders. (n.d.). https:\/\/rarechromo.org\/"},{"key":"e_1_3_3_46_1","doi-asserted-by":"crossref","unstructured":"Volkmar F. Siegel M. Woodbury-Smith M. King B. McCracken J. State M. (2014). Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder. Journal of the American Academy of Child & Adolescent Psychiatry 53(2) 237\u2013257. https:\/\/doi.org\/10.1016\/j.jaac.2013.10.013","DOI":"10.1016\/j.jaac.2013.10.013"},{"key":"e_1_3_3_47_1","unstructured":"What are the risks and limitations of genetic testing? MedlinePlus genetics. (n.d.). https:\/\/medlineplus.gov\/genetics\/understanding\/testing\/riskslimitations\/"},{"key":"e_1_3_3_48_1","unstructured":"XSense\u00ae Fragile X with Reflex\u2014Test Detail\u2014Quest Diagnostics. (n.d.). https:\/\/testdirectory.questdiagnostics.com\/test\/test-detail\/16313\/xsense-fragile-x-with-reflex?cc=MASTER"},{"key":"e_1_3_3_49_1","doi-asserted-by":"crossref","unstructured":"Xu L. Mitchell L. C. Richman A. R. Clawson K. (2016). What do parents think about chromosomal microarray testing? A qualitative report from parents of children with autism spectrum disorders. Autism Research and Treatment 2016 6852539. https:\/\/doi.org\/10.1155\/2016\/6852539","DOI":"10.1155\/2016\/6852539"},{"key":"e_1_3_3_50_1","doi-asserted-by":"crossref","unstructured":"Zebolsky A. Vos D. Soares N. (2020). Awareness of genetic testing for children with autism spectrum disorder among caregivers in an autism support group. Journal of Community Genetics 11(4) 405. https:\/\/doi.org\/10.1007\/s12687-020-00469-1","DOI":"10.1007\/s12687-020-00469-1"},{"key":"e_1_3_3_51_1","doi-asserted-by":"crossref","unstructured":"Zhang Y. Li N. Li C. Zhang Z. Teng H. Wang Y. Zhao T. Shi L. Zhang K. Xia K. Li J. Sun Z. (2020). Genetic evidence of gender difference in autism spectrum disorder supports the female-protective effect. Translational Psychiatry 10 4. https:\/\/doi.org\/10.1038\/s41398-020-0699-8","DOI":"10.1038\/s41398-020-0699-8"},{"key":"e_1_3_3_52_1","doi-asserted-by":"crossref","unstructured":"Zhang Z. Kramer J. Wang H. Chen W.-J. Huang T.-Y. Chen Y.-J. Tseng T.-S. Chen L.-S. (2022). Attitudes toward pursuing genetic testing among parents of children with autism spectrum disorder in Taiwan: A qualitative investigation. International Journal of Environmental Research and Public Health 19(1) Article 1. https:\/\/doi.org\/10.3390\/ijerph19010118","DOI":"10.3390\/ijerph19010118"},{"key":"e_1_3_3_53_1","doi-asserted-by":"crossref","unstructured":"Zhao S. Chen W.-J. Dhar S. U. Eble T. N. Kwok O.-M. Chen L.-S. (2021). Pursuing genetic testing for children with autism spectrum disorders: What do parents think? Journal of Genetic Counseling 30(2) 370\u2013382. https:\/\/doi.org\/10.1002\/jgc4.1320","DOI":"10.1002\/jgc4.1320"},{"key":"e_1_3_3_54_1","doi-asserted-by":"crossref","unstructured":"Zhao S. Chen W.-J. Kwok O.-M. Dhar S. U. Eble T. N. Tseng T.-S. Chen L.-S. (2021). Psychometric properties of the POAGTS: A tool for understanding parents\u2019 perceptions regarding autism spectrum disorder genetic testing. International Journal of Environmental Research and Public Health 18(6) 3323. https:\/\/doi.org\/10.3390\/ijerph18063323","DOI":"10.3390\/ijerph18063323"},{"key":"e_1_3_3_55_1","doi-asserted-by":"crossref","unstructured":"Zhou M. Zhang Y.-M. Li T. (2023). Knowledge attitudes and experiences of genetic testing for autism spectrum disorders among caregivers patients and health providers: A systematic review. World Journal of Psychiatry 13(5) 247\u2013261. https:\/\/doi.org\/10.5498\/wjp.v13.i5.247","DOI":"10.5498\/wjp.v13.i5.247"}],"container-title":["Autism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13623613241289980","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/13623613241289980","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13623613241289980","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:50:15Z","timestamp":1777380615000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/13623613241289980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1177\/13623613241289980"],"URL":"https:\/\/doi.org\/10.1177\/13623613241289980","relation":{},"ISSN":["1362-3613","1461-7005"],"issn-type":[{"value":"1362-3613","type":"print"},{"value":"1461-7005","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]}}}